Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 3/2010

01-09-2010 | Original Article

Prevalence of Transfusion Transmitted Infections in Voluntary and Replacement Donors

Authors: Hilda Fernandes, Prema Fancy D’souza, Pushpa Maria D’souza

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 3/2010

Login to get access

Abstract

The aim of the study was to find out the prevalence of transfusion transmitted infections (TTI) in voluntary and replacement donors. A total of 9599 donors were analysed for the prevalence of TTI over a period of 2 years.Of these 61.2% were voluntary donors and 38.8% were replacement donors. Prevalence of TTI in total donors was 0.6%. Prevalence of hepatitis B was highest (0.34%) followed by syphilis (0.11%), HIV&HCV (0.06%) and malaria (0.01%). Prevalence was more in male replacement donors. Extensive donor selection and screening procedures will help in improving the blood safety.
Literature
1.
go back to reference Widman FK (ed) (1985) Technical manual. American Association of Blood Banks, Arlington, pp 325–344 Widman FK (ed) (1985) Technical manual. American Association of Blood Banks, Arlington, pp 325–344
2.
go back to reference Gupta PK, Kumar H, Basannar DR, Jaiprakash M (2006) Transfusion transmitted infections in armed forces: prevalence and trends. MJAFI 62:348–350 Gupta PK, Kumar H, Basannar DR, Jaiprakash M (2006) Transfusion transmitted infections in armed forces: prevalence and trends. MJAFI 62:348–350
3.
go back to reference Kakkar N, Kaur R, Dhanoa J (2004) Voluntary donors—need for a second look. Indian J Pathol Microbiol 47:381–383PubMed Kakkar N, Kaur R, Dhanoa J (2004) Voluntary donors—need for a second look. Indian J Pathol Microbiol 47:381–383PubMed
4.
go back to reference Garg S, Mathur DR, Garg DK (2001) Comparison of seropositivity of HIV. HBV, HCV and syphilis in replacement and voluntary blood donors in western India. Indian J Pathol Microbiol 44:409–412PubMed Garg S, Mathur DR, Garg DK (2001) Comparison of seropositivity of HIV. HBV, HCV and syphilis in replacement and voluntary blood donors in western India. Indian J Pathol Microbiol 44:409–412PubMed
5.
go back to reference Sing B, Verma M, Verma K (2004) Markers for transfusion associated hepatitis in north Indian blood donors: prevalence and trends. Jpn J Infect Dis 57:49–51 Sing B, Verma M, Verma K (2004) Markers for transfusion associated hepatitis in north Indian blood donors: prevalence and trends. Jpn J Infect Dis 57:49–51
6.
go back to reference Asif N, Kokhar N, Ilahi F (2004) Seroprevalence of HBC, HCV and HIV infection among voluntary non-remunerated and replacement donors in northern Pakistan. Pak J Med Sci 1:24–28 Asif N, Kokhar N, Ilahi F (2004) Seroprevalence of HBC, HCV and HIV infection among voluntary non-remunerated and replacement donors in northern Pakistan. Pak J Med Sci 1:24–28
7.
go back to reference Matee MIN, Magesa PM, Lyamuya EF (2006) Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar Es Salaam, Tanzania. BMC Public Health 6:21. doi:10.1186/1471-2458-6-21 CrossRefPubMed Matee MIN, Magesa PM, Lyamuya EF (2006) Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar Es Salaam, Tanzania. BMC Public Health 6:21. doi:10.​1186/​1471-2458-6-21 CrossRefPubMed
8.
go back to reference Srikrishna A, Sitalaxmi S, Prema Damodar S (1999) How safe are our safe donors? Indian J Pathol Microbiol 42:411–416PubMed Srikrishna A, Sitalaxmi S, Prema Damodar S (1999) How safe are our safe donors? Indian J Pathol Microbiol 42:411–416PubMed
9.
go back to reference Ekadashi R, Langer S (2009) Seroprevalence of Human Immunodeficiency Virus and syphilis in blood donors of Delhi. Indian J Microbiol 27:167–168 Ekadashi R, Langer S (2009) Seroprevalence of Human Immunodeficiency Virus and syphilis in blood donors of Delhi. Indian J Microbiol 27:167–168
10.
go back to reference Mujeeb SA, Mehmood K (1996) Prevalence of HBV, HCV and HIV infections among family blood donors. Ann Saudi Med 16:702–703PubMed Mujeeb SA, Mehmood K (1996) Prevalence of HBV, HCV and HIV infections among family blood donors. Ann Saudi Med 16:702–703PubMed
11.
go back to reference Makroo RN, Sahil P, Vashist RP, Lal S (1996) Trends of HIV infection in blood donors of Delhi. Indian J Pathol Microbiol 39:139–142PubMed Makroo RN, Sahil P, Vashist RP, Lal S (1996) Trends of HIV infection in blood donors of Delhi. Indian J Pathol Microbiol 39:139–142PubMed
12.
go back to reference Choudhury N, Phadke S (2001) Transfusion transmitted disease. Indian J Paediatr 68:951–958CrossRef Choudhury N, Phadke S (2001) Transfusion transmitted disease. Indian J Paediatr 68:951–958CrossRef
13.
go back to reference Sawke N, Sawke GK, Chawla S (2010) Seroprevalence of common transfusion—transmitted infections among blood donors. People’s J Sci Res 30:5–7 Sawke N, Sawke GK, Chawla S (2010) Seroprevalence of common transfusion—transmitted infections among blood donors. People’s J Sci Res 30:5–7
14.
go back to reference Chandra T, Kumar A, Gupta A (2009) Prevalence of transfusion transmitted infections in blood donors: an Indian experience. Trop Doct 39:152–154CrossRefPubMed Chandra T, Kumar A, Gupta A (2009) Prevalence of transfusion transmitted infections in blood donors: an Indian experience. Trop Doct 39:152–154CrossRefPubMed
Metadata
Title
Prevalence of Transfusion Transmitted Infections in Voluntary and Replacement Donors
Authors
Hilda Fernandes
Prema Fancy D’souza
Pushpa Maria D’souza
Publication date
01-09-2010
Publisher
Springer-Verlag
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 3/2010
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-010-0044-0

Other articles of this Issue 3/2010

Indian Journal of Hematology and Blood Transfusion 3/2010 Go to the issue

Editorial

Editorial

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine